B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma

SIMPLE SUMMARY: Although chemotherapy is associated with high relapse rates and numerous side effects, it is still used as the front line treatment of anaplastic large cell lymphoma (ALCL). Therefore, alternative treatment options for ALCL are needed. In this study, we show that B7-H3 is a novel and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zi, Zhenguo, Zhao, Haihong, Wang, Huanyu, Ma, Xiaojing, Wei, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766167/
https://www.ncbi.nlm.nih.gov/pubmed/33348781
http://dx.doi.org/10.3390/cancers12123815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766167/
https://www.ncbi.nlm.nih.gov/pubmed/33348781
http://dx.doi.org/10.3390/cancers12123815

Ejemplares similares